impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel
Published 1 year ago • 158 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
2:58
the impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel
-
3:02
the effects of maintenance therapy on real-world outcomes for patients with ndmm
-
2:39
allogeneic therapy for the treatment of refractory hematological malignancies
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
2:53
understanding how patients relapse from car t-cell therapy
-
1:06:04
itp: novel treatments
-
1:54
feasibility and impact of digital health interventions on the qol of patients with r/r myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:53
the future of multiple myeloma treatment
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:47
advice for physicians when managing bispecific antibody treatment for patients with myeloma
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:01
car-t: myeloma toxicities
-
3:41
emerging therapies for r/r myeloma
-
4:02
moving car-t therapy into earlier lines of treatment for myeloma and the need for effective bridging
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:02
maintenance therapy following treatment for amyloidosis
-
2:25
the challenges associated with myeloma bone disease
-
1:19
al amyloidosis: mrd negativity